1103014
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 9, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Washington, DC (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)